Tag: Guide

How a US MedTech Startup Achieved NMPA Class II Medical Device Approval in 12 Months: China Case Study In under 12 months, a US-based digital health s

How Novartis Registered Kymriah (CAR-T) with NMPA in China | Cell Therapy Case Study body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-ser

How BeiGene Navigated CDE Clinical Trial Approvals for Tislelizumab in China | Biotech Case Study body { font-family: 'Segoe UI', Tahoma, Geneva, Verd

How Pfizer Accelerated a Rare Disease Drug Through China's NMPA Priority Review: Biotech Case Study | China-Gateway360 body { font-family: 'Segoe UI',

Biosimilar vs Innovative Biologic: Which NMPA Registration Strategy in China Offers Faster Market Access? | China-Gateway360 body { font-family: 'Sego

Contract Manufacturing vs In-House Production: Which Biologics Manufacturing Approach in China Costs Less? body { font-family: 'Segoe UI', Roboto, Ari